Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After Knee or Hip Replacement Surgery

NCT01660763 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

419

Enrollment

INDUSTRY

Sponsor class

Conditions

Post Operative Pain

Interventions

DRUG: Sufentanil NanoTab PCA System/15 mcg
DRUG: Placebo Sufentanil NanoTab PCA System

Sponsor

Talphera, Inc